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ABSTRACT 
  
 
 
Functional Characterization of a Novel POK family Transcription Factor, 
ZBTB5, in the Transcriptional Regulation of Cell Cycle Arrest p21CIP1 
Gene 
 
 
Dong-In Koh 
 
 
Department of Medical Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Man-Wook Hur) 
 
 
 
Transcriptional repression through chromatin remodeling and histone 
deacetylation has been postulated as a driving force for tumorigenesis. We isolated 
and characterized a novel POZ domain Krüppel-like zinc finger transcription 
repressor, ZBTB5 (zinc finger and BTB domain-containing 5). Serial analysis of gene 
expression (SAGE) analysis showed that ZBTB5 expression is higher in 
retinoblastoma and muscle cancer tissues. Immunocytochemistry showed that ZBTB5 
was localized to the nucleus, particularly nuclear speckles. ZBTB5 directly repressed 
transcription of cell cycle arrest gene p21 by binding to the proximal GC-box 5/6 
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elements and the two distal p53-responsive elements (bp -2323 ~ -2299; bp -1416 ~ 
-1392). Chromatin immunoprecipitation assays showed that ZBTB5 and p53 
competed with each other in occupying the p53 binding elements. ZBTB5 interacted 
with corepress or histone deacetylase complexes such as BCoR (BCL-6-interacting 
corepressor), NCoR (nuclear receptor corepressor), and SMRT (silencing mediator for 
retinoid and thyroid receptors) via its POZ domain. These interactions resulted in 
deacetylation of histones Ac-H3 and Ac-H4 at the proximal promoter, which is 
important in the transcriptional repression of p21.    
MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays and 
fluorescent-activated cell sorter analysis revealed that ZBTB5 stimulated both cell 
proliferation and cell cycle progression, significantly increasing the number of cells in 
S-phase. Overall, our data suggest that ZBTB5 is a potent transcription repressor of 
cell cycle arrest gene p21 and a potential proto-oncogene stimulating cell 
proliferation. 
 
Key words: ZBTB5, p53, p21, Sp1, Transcriptional factor, BTB/POZ protein  
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Ι. INTRODUCTION 
The POZ domain, an evolutionarily conserved protein-protein interaction motif 
found in many regulatory proteins1-2, was originally identified in Drosophila 
melanogaster bric-á- brac, tramtrack, and broad complex transcription regulators and 
in many pox virus zinc finger proteins3-4. As many as 184 known human proteins, 96 
Drosophila proteins, and 137 Caenorhabditis elegans proteins are estimated to 
contain the POZ domain (SMART data base). POZ domain proteins are involved in 
many critical cellular processes such as apoptosis5, development6-7, ion channel 
activity4, oncogenesis8–10, and transcription10–16. In particular, some of the POZ 
domain Krüppel-like zinc finger (POK) proteins are the major determinants of 
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development, differentiation, and oncogenesis. For instance, promyelocytic leukemia 
zinc finger (PLZF)-null mice display severe defects in limb development and germ 
stem cell maintenance7,17. Th-POK (T-helper-inducing POZ/Kru¨ppel- like factor, 
also known as cKrox) has been recently reported as a master regulator of T-cell 
lineage commitment18. BCL-6(B cell lymphoma transcription factor-6), PLZF, and 
HIC1 (Hypermethylated In Cancer) have been implicated in non- Hodgkin lymphoma, 
acute promyelocytic leukemia, and spontaneous malignant tumors, respectively8- 9,19. 
Recently, FBI-1 (also called Pokemon/LRF/ZBTB7A) was characterized as a 
proto-oncogenic transcription factor regulating ARF and Rb (retinoblastoma) genes10, 
20 and also as a critical determinant of B versus T lymphoid lineage fate21.          
The most striking and common property of POZ domain transcription factors is 
their ability to repress transcription via their POZ domains12–16,20, although a few 
actually activate transcription, such as FBI-1 and MIZ-1 in certain promoter 
contexts22-23. This characteristic probably underlies many biological processes 
controlled by these factors. The ability of the domain to interact with other key 
regulatory proteins such as corepressor proteins and other transcription factors 
appears to be important for repression. In particular, the POZ domains of human 
PLZF and BCL-6 have been shown to interact with SMRT/N-CoR, mSin3A, BCoR, 
and histone deacetylase12–16,20. Chromatin compaction by histone deacetylase complex 
recruited by the POZ domain was suggested to repress transcription in the case of 
PLZF-RAR a fusion protein13, 24, 26.  
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The cyclin-dependent kinase inhibitor p21 is a major player in cell cycle arrest in 
mammalian cells and the downstream cell-cycle regulator of the ARF-HDM2 
-p53-p21 pathway27–29. The p21 gene, mainly regulated at the transcriptional level, is 
a transcriptional target of tumor suppressor p53 and plays a crucial role in mediating 
growth arrest when cells are exposed to DNA-damaging agents. Overexpression of 
p21 results in G1-, G2-, or S-phase arrest upon exposure to DNA-damaging 
agents30–32. Whereas induction of p21 predominantly leads to cell cycle arrest, 
repression of p21 may have a variety of outcomes depending on the cellular context29. 
Aside from p53, a variety of other factors including specificity proteins 1 and 3 
(Sp1/Sp3), Smads, Ap2, STAT, BRCA1, E2F-1/E2F-3, and C/EBPα and ß-activate 
the transcription of p2129 In addition to its role responding to DNA damage, p21 has 
also been implicated in terminal differentiation, replicative senescence, and protection 
from p53-dependent and -independent apoptosis29.  
Sp1 family transcription factors that bind at the proximal promoter (bp -120 to -50) 
represent another group of major regulators that affect p21 gene expression29. Sp1 is 
one of the best characterized transcription factors that bind to GC-rich DNA 
sequences in numerous cellular and viral genes33-34. The six Sp1 binding GC boxes of 
the p21 proximal promoter have been shown to be important; mutation of the sites not 
only significantly affects transcription but also disrupts synergistic transcription 
activation by Sp1 and p53 and other signals that regulate p21 gene transcription29,35. 
Among the six GC boxes found in this region, GC-box 3 mediates p21 induction by 
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various agents such as transforming growth factor-ß, butyrate, the histone deacetylase 
inhibitor trichostatin A, lovastatin, and Ca2+. In contrast, GC-boxes 1 and 2 mediate 
transcriptional activation by phorbol esters and okadaic acid, the tumor suppressor 
protein BRCA1, and gut-enriched Krüppel-like factor (GKLF, KLF4). To date, no 
specific role has been attributed to the most proximal and overlapping GC boxes 5 
and 629. Together, these observations suggest that the specificity of utilizing different 
proximal GC-boxes under different p21 regulation conditions is important.  
From the analysis of amino acid sequences of all available human POZ-domain 
proteins, we identified a novel ZBTB5 POK protein with a POZ-domain and two 
unique zinc finger domains. We investigated whether ZBTB5 could regulate any 
components of the ARF-HDM2-p53-p21 pathway and examined the mechanisms and 
physiological consequences of ZBTB5 action. ZBTB5 repressed transcription of the 
p21 gene and significantly increased cell proliferation. Our data suggest that ZBTB5 
may be an important transcription regulator of p21 and may play a critical role in 
regulating important biological processes controlled by p21.  
 
 
 
 
 
 
 7
Π. MATERIALS AND METHODS 
 
1. Plasmids, Antibodies, and Reagents 
p21-Luc plasmid was kindly provided by Dr. Yoshihiro Sowa of the Kyoto 
Perpetual University of Medicine (Kyoto, Japan). The various pGL2-p21-Luc, 
pGL2-p53-Luc, pGL2-ARF-Luc, pGL2-HDM2-Luc, pcDNA3.1-p53, pcDNA3.1-Sp1, 
pG5-5x(GC-box)-Luc, corepressor expression vectors, and VP16-corepressors we 
used have been reported elsewhere or were prepared by us20,23,25. The 
pcDNA3-ZBTB5 plasmid was prepared by cloning a cDNA fragment (KIAA0354) 
into pcDNA3.0. The GAL4-POZZBTB5 plasmid was prepared by cloning a cDNA 
fragment (encoding amino acids 1–135) into a pCMX-Gal4 plasmid. To prepare 
recombinant GST-POZZBTB5 and GST-ZFZBTB5 proteins, cDNA fragments 
encoding the POZ domain (amino acids 1–123) and zinc fingers (amino acids 
612–766) were cloned into pGEX4T3. All plasmid constructs were verified by DNA 
sequencing. Antibodies against p21, p53, Sp1, glyceraldehyde-3-phosphate 
dehydrogenase, FLAG tag, Ac-H3, Ac-H4, HDAC3, and SMRT were purchased from 
Upstate (Charlottesville, VA), Chemicon (Temecula,CA), Calbiochem, and Santa 
Cruz Biotechnology (Santa Cruz, CA). Most of the chemical reagents were purchased 
from Sigma. 
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2. Cell Cultures 
HEK293A, HCT116 p53-/-, and CV-1 cells were cultured in Dulbecco’s modified 
eagle medium supplemented with 10% fetal bovine serum. Saos-2 cells were cultured 
in McCoy’s 5A medium supplemented with 15% fetal bovine serum. Transcriptional 
Analysis of ARF-, HDM2-, p53-, p21-, and p53-responsive Promoter : pGL2-ARF- 
Luc, pGL2-HDM2-Luc, pGL2-p53-Luc, pG13-Luc, pG5-5x(GC-box)-Luc, and 
various pGL2-p21-Luc promoter reporter fusion plasmids as well as pcDNA3-ZBTB5, 
pcDNA3.1-p53, and pCMV-LacZ in various combinations were transiently 
transfected into various cell lines (HEK293A, HCT116, Saos-2, and CV-1) using 
Lipofectamine Plus reagent (Invitrogen). After 24–36 h of incubation, cells were 
harvested and analyzed for luciferase activity. Reporter activity was normalized with 
contransfected ß-galactosidase activity for transfection efficiency. Cells were seeded 
in the 96-well plate and incubated for 16 hr. The cells were co-treated with 30 μM 
TBB(SIGMA-Aldrich, St-Louis, MO, USA) and 500 ng/ml TRAIL(ATGen, 
Sungnam, Korea) for 3 hr. For the measurement of cell viability, MTT assay was 
performed. Briefly, cells were incubated with 2 mg/ml MTT (SIGMA-Aldrich) for 2 
hr. The supernatants were then removed and 100 μl DMSO (Duchefa, BH Haarlem, 
The Netherlands) was added to the 96-well plate. Absorbance was recorded at 570nm 
using SpectraMax ELISA reader. The data are expressed as mean±s.d. for 
quardruplicate, and similar results were obtained from two independent experiments. 
 
 9
3. Quantitative real-time PCR of ZBTB5 mRNA expression in cells and RT-PCR 
of total RNA prepared from FVB mouse tissues 
Total RNA was isolated from HEK293A cells using TRIzol reagent (Invitrogen). 
cDNAs were synthesized using 5 μg of total RNA, random hexamer (10 pmol), and 
Superscript reverse transcriptase II (200 units) in 20μl using a reverse transcription kit 
(Invitrogen). qPCR was performed using SYBR Green Master Mix (Applied 
Biosystems). The following qPCR oligonucleotide primers sets were used: ZBTB5 
forward, 5’-CCACTAGTGACTGCAGGCTG-3’, ZBTB5 reverse, 5’-CCTGCATAG 
GCCTGACGAA- 3’; p21 forward, 5’-AGGGGACAGCAGAGGAAG-3’, p21 rever 
se, 5’-GCGTTTGGAGTGGTAGAAATCTG-3’; GAPDH forward, 5’-CCCCTTCAT 
TGACCTCAACTAC-3’, GAPDH reverse, 5’-TCTCGCTCCTGGAAGATGG-3’.  
To analyze ZBTB5 mRNA expression in FVB mouse, total RNA was isolated as 
described above from mouse brain, heart, liver, muscle, kidney, spleen, brown 
adipose tissues, and white adipose tissues, and RT-PCR was carried out using the 
following oligonucleotide primer sets ZBTB5 mRNA forward, 5’-TTGCTGTTCAC 
AGCTGCCAC-3’; reverse, 5’-TTAGCCTGCGGGCCTTCCAC-3’. 
 
4. Western blot analysis 
Cells were harvested and lysed in RIPA buffer (50 mM Tris-HCl pH8.0, 1% 
NP-40, 0.25% sodium deoxycholic acid, 150 mM NaCl, 1 mM EGTA, complete 
Mini-Protease cocktail). Cell extracts (40 ㎍) were separated using 12% SDS-PAGE 
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gel electrophoresis, transferred onto Immun-BlotTM PVDF membranes (Bio-Rad, CA), 
and blocked with 5% skim milk (BD Biosciences, MD). Blotted membranes were 
incubated with antibodies against FLAG-tag (Sigma), GAPDH (Chemicon, CA), p21, 
p53, Sp1 (SantaCruz Biotech, CA) and then incubated with anti-mouse or rabbit 
secondary antibody conjugated with HRP (Vector Laboratory, CA). Protein bands 
were visualized with ECL solution (PerkinElmer, CA).  
 
5. Knock-down of ZBTB5 mRNA by siRNA 
Four siRNA against ZBTB5 mRNA were designed and purchased from 
Dharmacon(Lafayette,CO):siZBTB5-1,5’-AACUUUACU-3’,5’-AGUAAAGUUAU-
3’;siZBTB5-2,5’-AGCUCGCAA-3’,5’-UUGCGAGCUCC-3’;siZBTB5-3,5’-UCCUC
AUUU-3’,5’-AAAUGAGGACG-3’;siZBTB5-4,5’-UAAUGGAUG-3’,5’-CAUCCA
UUACA-3’. siRNA (200pmoles) were transfected into HEK293A cells using 
Lipofectamine 2000 (Invitrogen, CA). After transfection, the cells were harvested, 
total RNA was prepared, and RT-PCR analysis of mRNA was performed as described 
above. 
 
6. Quantitative chromatin immunoprecipitation (qChIP) assays 
    The molecular interaction between ZBTB5 and p53 or Sp1 on the p21 promoter 
and histone modification at the p21 proximal promoter in HEK293A, Saos-2 and 
Drosophila SL2 cells, were analyzed by following standard qChIP assay protocol, as 
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described elsewhere20,23,36.  
Qualtitative PCR of chromatin immunoprecipitated DNA was carried out using 
oligonucleotide primer sets designed to amplify the upstream regulatory regions 
around p53 binding sites and the proximal promoter region of the p21 gene: p53 
RE#1 binding primers (bp:-2307~-1947), forward, 5’-CTGTGGCTCTGATTGGCTT 
-3’, reverse, 5’- GGGTCTTTAGAGGTCTCCTGTCT-3’; p53 RE#2 binding primers 
(bp: -1462~-1128), forward, 5’- CCACAGCAGAGGAGAAAGAAG -3’, reverse, 5’- 
GCTGCTCAGAGTCTGGAAATC-3’. To analyze histone H3 and H4 modification at 
the proximal promoter (bp -133 to +100), forward, 5’-GATCGGTACCGCGCTGGGC 
AGCCAGGAGCCT-3’, reverse,5’-TCGTCACCCGCGCACTTAGA-3’ primers were 
used. Control 3’UTR region of p21 gene, forward, 5’-TCCTTCCCATCGCTGTC 
ACA-3’, reverse, 5’-GTCACCCTGCCCAACCTTAG-3’. 
 
7. Immunoprecipitation assays 
Cells transfected with pcDNA3-FLAG-ZBTB5 expression vector were washed, 
pelleted, and resuspended in a lysis buffer supplemented with protease inhibitors (20 
mM Tris-HCl, pH7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100). Cell lysate 
was precleared, and the supernatant was incubated overnight with anti-FLAG 
antibody on a rotating platform at 4℃, followed by incubation with protein 
A-Sepharose Fast Flow beads. Beads were collected, washed, and resuspended in 
equal volumes of 5x SDS loading buffer. Immunoprecipitated proteins were separated 
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with 12% SDS-PAGE. The western blot assay was performed as described above. 
 
8. Mammalian two-hybrid assays 
HEK293A cells (or CV-1 cells) were co-transfected with pG5-Luc, 
pGal4-POZZBTB5, pVP16-corepressors, and pCMV-LacZ using Lipofectamin Plus 
(Invitrogen, CA). After 36 hrs of transfection, cells were harvested and assayed for 
luciferase activity. Luciferase activity was then normalized with co-transfected 
β-galactosidase activity. 
 
9. GST fusion protein purification, in vitro transcription and translation of 
corepressors, p53, or Sp1, and pull-down assays  
Recombinant GST, GST-POZZBTB5, and GST-ZFZBTB5 fusion proteins were 
prepared from E. coli BL21 (DE3) grown for 4 hrs at 37℃ in a medium containing 1 
mM IPTG. The E. coli were lysed and purified using glutathione-agarose 4 bead 
affinity chromatography (Peptron, Taejeon, Korea). The purified proteins were then 
resolved with 12% SDS-PAGE to quantitate and assess purity. Corepressor, p53, and 
Sp1 polypeptides were prepared by incubating 1 µg of pcDNA3-corepressor, 
pcDNA3.1-p53, and pcDNA3.1-Sp1 expression plasmid with TNT Quick-coupled 
Transcription/Translation Extract (Promega, WI) containing 40 ㎕ of TNT Quick 
Master Mix and 2 µl of [35S]-methionine (1175.0 Ci/mol) (PerkinElmer Life Sciences, 
MA) at 30°C for 90 min. Polypeptide expression levels were then analyzed by 
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running 1 ㎕ of the total mixture through 12% SDS-PAGE and autoradiography. 
For GST-fusion protein pull-down assays, GST-fusion protein-agarose bead 
complexes were incubated with 10 ㎕ of in vitro translated [35S]-methione–labeled 
corepressors, p53, and Sp1 polypeptides at 4°C for 4 hrs in HEMG buffer. The 
reaction mixtures were centrifuged, pellets were rinsed, and the bound proteins were 
separated using 12% SDS-PAGE. Gels were then exposed to X-ray film using an 
image-intensifying screen (Kodak, NY). 
 
10. Preparation of recombinant adenovirus overexpressing ZBTB5 
ZBTB5 cDNA was cloned into the adenovirus E1 shuttle vector pCA14 
(Microbix; Ontario, Canada), to generate pCA14-ZBTB5. The pCA14-ZBTB5 shuttle 
vector was linearized by XmnI digestion, and the adenovirus vector vmdl324Bst 
(from Dr. Verca at the University of Fribourgh, Switzerland) containing the Ad5 
genome deleted in the E1 and E3 region was also linearized with BstBI digestion. The 
linearized pCA14-ZBTB5 and the vmdl324Bst digested with BstBI were 
co-transformed into E. coli BJ518 for homologous recombination. TProper 
homologous recombinant adenoviral plasmid was digested with PacI and tranfected 
into 293 cells to generate the adenovirus expressing ZBTB5 (dl324-ZBTB5). 
Propagation and titration of the recombinant virus was carried out by standard 
methods. PCR amplification and DNA sequencing using primers specific to ZBTB5 
confirmed the adenovirus genotype. 
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11. EMSA (Electro-Mobility Shift Assay) 
EMSAs were carried out as described previously20,23,36. The probe sequences of Sp1 
response elements on the p21 proximal promoter or the sequences of p53 response 
elements on the p21 distal promoter used in EMSA were as follows (only top strands 
are shown): GC-box 1, 5’-GATCGGGAGGGCGGTCCCG-3’; GC-box2, 5’-GATCC 
CGGGCGGCGCG-3’; GC-box3, 5’-GATCCGAGCGCGGGTCCCGCTC-3’; GC- 
box4, 5’-GATCCTTGAGGCGGGCCCG-3’; GC-box 5/6, 5’-GATCGGGCGGGGCG 
GTTGTATATCA-3’; p53 Re #1, 5’-GATCCGTTAGAGGA AGAAGACTGGGCATG 
TCTG-3’; p53 RE2 #2, 5’-GATCCATCAGGAACATGTCCCAACATGTTGAGCTC 
-3’. 
 
12. Immunocytochemistry 
HEK 293A cells were transfected with pcDNA3-ZBTB5 plasmid, washed, and 
fixed with cold methanol/formaldehyde. Cells were permeabilized, washed, blocked 
with horse serum, and cells were incubated with mouse anti-His primary antibody. 
After thorough washing, cells were further incubated with FITC-conjugated 
anti-mouse IgG secondary antibody and, finally, the cells were soaked with solution 
containing 4, 6-diamidino-2-phenylindole (1 mg/ml). The cells were mounted and 
examined with Carl Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss, 
Germany). 
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13. FACS analysis 
HEK293A cells were transfected with ZBTB5 expression vector or siZBTB5 
RNA. The cells were washed, fixed with methanol, and stained with 50 μg/ml 
propidium iodide in100 μg/ml ribonuclease A for 30 min at 37°C in the dark. DNA 
content, cell cycle profiles, and forward scatter were analyzed with a FACS Calibur 
(BD Biosciences), with emission detection at 488 nm (excitation) and 575 nm (peak 
emission). Data were analyzed using ModFit LT 2.0 (Verity Software House, Inc., 
ME) and WindMDI 2.8 (Joseph Trotter, Scripps Research Institute, CA). 
 
14. MTT assay 
Confluent HEK293A cells grown on 10 cm culture dishes were transfected with 
ZBTB5 expression vector or siZBTB5 RNA in the presence or absence of p53 
expression vector. And cells (1.5x105 cells) were transferred to 6 well culture dish and 
grown for 0-6 days. At 0, 2, 4, 6 days, cells were incubated 1 h at 37°C with 20μl/well 
MTT (2 mg/ml). Precipitates were dissolved with 1 ml of dimethylsulfoxide. Cellular 
proliferation was determined from the conversion of MTT to formazan using a 
SpectraMAX 250 (Molecular Device Co., Sunnyvale, CA) at 570 nm 
 
 
15. BrdUrd incorporation 
HEK293A cells were plated at 40% confluency and transfected for 48 hrs with 
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1.68 μg siRNA, pcDNA3-FBI-1-FLAG, or pcDNA3. Cells were incubated 4 h in 
DMEM with BrdUrd (20μM), washed, fixed, permeabilized, incubated 2 h with an 
anti-BrdUrd monoclonal antibody, washed, and incubated 1 h with an AlexaFluor 488 
goat anti-mouse IgG secondary antibody. Nuclei were stained with DAPI for 10 min. 
HeLa cells were analyzed with a Radiance 2100 Laser Scanning System (Bio-Rad). 
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Ш. RESULTS 
 
1. ZBTB5 is a New BTB/POK protein that represses transcription of the p21 
and HDM2 genes of the p53 pathway. 
We isolated and characterized a novel member of the human POZ protein family, 
ZBTB5 (zinc finger and BTB domain-containing 5 or KIAA0354), which encodes a 
protein of 677 amino acid residues. ZBTB5 has a POZ domain at its N terminus 
(amino acids 1–123) and two zinc finger domains at its C terminus (amino acids 613– 
664) (Fig. 1A; supplementary Fig. 1). Serial analysis of gene expression (SAGE) 
analysis shows that ZBTB5 is expressed in most human tissues, and our RT-PCR 
analysis of mouse total RNA showed that mouse Zbtb5 is also expressed ubiquitously, 
with particularly high expression in spleen and white adipose tissues (supplementary 
Fig. 3B). Immunocytochemistry revealed nuclear localization of ZBTB5 
(supplementary Fig. 3C). Interestingly, ZBTB5 is highly expressed in retina and 
muscle cancer tissues (cgap.nci.nih.gov). 
Recently, several reports have implicated POZ domain proteins such as FBI-1, 
BCL-6, and Miz-1 in cell cycle regulation, differentiation, development, and 
oncogenesis10,20,22. We investigated whether ZBTB5 influenced expression of genes of 
the p53 pathway, which are important in the regulation of cell cycle. ZBTB5 
expression vector and various promoter-Luc fusion reporter constructs were 
transiently co-transfected and analyzed for reporter luciferase gene expression in 
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HEK293A cells. ZBTB5 repressed transcription of p21 and HDM2 gene expression 
by 70 and 35%, respectively (Fig. 1B). The ectopic ZBTB5 expressed by plasmid or 
recombinant ZBTB5 adenovirus repressed endogenous p21 gene transcription (Fig. 1, 
C and D). Alternatively, knock-down of ZBTB5 mRNA by siRNA derepressed 
endogenous p21 transcription in HEK293A cells (Fig. 1, E and F).  Overall, our data 
suggest that ZBTB5 is a transcription repressor of p21 gene.  
 19
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Figure 1. ZBTB5 represses transcription of the p21 and HDM2 genes in 
HEK293A cells. (A) Structure of the ZBTB5 protein. Open box, POZ domain; 
numbered open circles, zinc fingers. (B) Transcription assays of p53 pathway genes 
by ZBTB5. ZBTB5 expression vector and promoter-luciferase fusion reporter plasmid 
were transiently co-transfected into HEK293A cells and luciferase activity was 
measured. (C) Western blot analysis of HEK293A cell lysates transiently transfected 
with ZBTB5 expression vector. GAPDH, control. (D) qRT-PCR analysis of the total 
RNA isolated from HCT116 and HEK293A cells transfected with either control 
adenovirus (dl324) or recombinant adenovirus (dl324-ZBTB5) overexpressing 
ZBTB5. (E) qRT-PCR analysis of the endogenous p21 and ZBTB5 mRNA after 
HEK293A cells were transfected with three different siRNAs targeting ZBTB5 or 
nonsilencing siRNA. Knock-down of ZBTB5 mRNA derepressed p21 gene 
expression. (F) Western blot analysis of HEK293A cell lysates transiently transfected 
with ZBTB5 siRNA, GAPDH, control. 
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2. ZBTB5 represses transcription of cell cycle arrest p21 gene an repression by 
ZBTB5 is dependent on p53 binding elements. 
We examined which regulatory elements of the p21 promoter were important for 
transcriptional repression of p21 by ZBTB5 in HEK293A cells. As ZBTB5 repressed 
transcription of the endogenous p21 gene (Fig. 1B). ZBZTB5 repressed transcription 
of two different promoter constructs (-1462 and -2307 bp) by 30–80%, and repression 
was particularly potent with the -2.3-kilobase promoter. Interestingly, ZBTB5 was not 
able to repress transcription of shorter promoter constructs (-864 and -131 bp) and 
instead significantly activated transcription of p21 (190–310%). ZBTB5 transcription 
activation was particularly potent with the shortest promoter construct (-131 bp), 
which is highly concentrated in Sp1 binding GC boxes (Fig. 2, A and B). It appears 
that ZTB5 significantly repressed transcription of the p21 promoter bearing a 
-2.3-kilobase upstream sequence containing the two distal p53-binding sites but that 
repression was somewhat weak with the -1.5-kilobase construct with one p53 binding 
element. These data suggest that transcriptional repression by ZBTB5 may involve 
p53 and distal p53 binding elements. 
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Figure 2. ZBTB5 represses transcription of the p21 gene by acting on the distal 
regulatory element containing p53 binding sites. (A) Structure of various p21 
promoter constructs tested. (B) Transcription assays. HEK293A cells were transiently 
co-transfected with ZBTB5 expression vector and pGL2-p21-Luc reporter plasmids 
with variable upstream sequences and analyzed for luciferase activity. 
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3. ZBTB5 represses transcriptional activation of p21 by p53 and binds to the 
p53 binding elements and proximal Sp1 binding GC-box 5/6 
Because ZBTB5 only significantly repressed transcription of the promoter with 
distal p53 binding sites, we suspected that the repression mechanisms involved p53 
and distal p53 binding elements. We investigated whether ZBTB5 could block the 
transcriptional activation of p21 by etoposide activated p53 or by ectopic p53 in 
HEK293A cells and HCT116 p53-/- cells lacking p53. In HEK293A cells, treatment 
with the DNA-damaging agent etoposide increased p21 gene expression by inducing 
p53, which was again repressed by ZBTB5 (Fig. 3A). Additional transcriptional 
analysis of pG5–6x(p53RE)-Luc with five copies of p53 binding elements of the p21 
gene in the proximal promoter showed that ZBTB5 blocked transcription activation 
by p53 in Saos-2 cells (Fig. 3B). Ectopic p53 expression in HCT116 p53-/- cells 
increased p21 gene expression, which was repressed by ZBTB5 (Fig. 3C). 
Interestingly, ZBTB5 increased p21 gene expression in HCT116 p53-/- cells, which is 
relevant with the transcription activation of the short p21 promoter lacking p53 
binding element in HEK293A cells (Fig. 2B).  
It is also important to note that ZBTB5 repressed transcription without the 
induced or ectopic p53 in HEK293A cells on the two promoter constructs (Fig. 3, A 
and B). These data suggest that ZBTB5 may inhibit transcription of the p21 gene by 
directly acting on the distal p53 binding elements. Indeed, EMSA showed that the 
zinc finger DNA binding domain of ZBTB5 can bind to p53RE-1 and -2 (Fig. 3, D 
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and E). Moreover, oligonucleotide pulldown assays showed that endogenous ZBTB5 
binds the elements (Fig. 3E). These results imply a two p53 binding elements and that 
the binding competition may be important in transcription repression. In addition, 
ZBZTB5 also bound to the proximal Sp1 binding GC-box 5/6, although relatively 
weakly compared with the p53 binding elements in EMSA (Fig. 3, D and E). 
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Figure 3. ZBTB5 represses transcription activation by p53. ZBTB5 binds to the 
distal p53 binding elements and proximal GC-box 5/6 of the p21 gene. (A)      
Transcription analysis in HEK293A cells. Etoposide treatment of the cells increased 
p21 gene expression, which was repressed by ZBTB5. (B) Transcriptional activation 
of pGL2-6x(p53RE)-Luc by ectopic p53 was repressed by ZBTB5 in Saos-2 cells 
lacking p53. p53RE, distal p53-binding element of p21. (C) Transcription analysis. 
HCT116 p53-/- cells lacking p53 were transiently co-transfected with a mixture of an 
expression vector of p53 and/or ZBTB5 and pGL2-p21-Luc Wt (-2.3 kb), and 
luciferase activity was measured. (D) EMSA. Two p32-α-dATP-labeled p53RE-1 and 
-2 probes and Sp1 binding GC-box 5/6 probes were incubated with GST-ZFZBTB5 
(0.5 μg) and separated by 4% nondenaturing PAGE. ZBTB5 bound to the distal p53 
binding elements and GC-box 5/6 of p21. ZFZBTB5, Zinc finger DNA binding 
domain of  ZBTB5. (E) Oligonucleotide pull-down assay of ZBTB5 binding to the 
p53 binding elements and proximal GC-box 5/6. HEK293A cells extracts were 
incubated with biotinylated double-stranded oligonucleotides. The mixtures were 
further incubated with streptavidin-agarose beads and precipitated by centrifugation. 
The precipitate was analyzed by Western blot assay using antibodies against ZBTB5 
and Sp1. 
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4. ZBTB5 and p53 compete with each other in binding to the p53 binding 
elements, but ZBTB5 dramatically increases Sp1 binding to the proximal 
GC-box 5/6 of endogenous p21 gene 
We tested whether the ZBTB5 and p53 proteins compete for sites on the 
endogenous p21 gene using quantitative ChIP assays. A FLAG-ZBTB5 expression 
vector was transiently transfected into HEK293A cells, and binding interactions were 
analyzed on the p53RE-1 and -2 and the proximal GC boxes of endogenous p21. ChIP 
assays using antibodies against FLAG tag and p53 revealed that ZBTB5 bound to 
p53RE-1 and -2 by competing with p53 in a dose-dependent manner (Fig. 4, B and C). 
In contrast, qChIP assays of binding of ZBTB5 and Sp1 on the proximal promoter of 
endogenous p21 revealed that ZBTB5 not only binds to the region but also 
dramatically increases Sp1 binding to the region (Fig. 4D), which may explain the 
synergistic transcription activation on the short p21 promoter construct.  
Although the functional significance of the binding of FLA-ZBTB5 to the 
proximal promoter GC boxes in the short promoter context remains unclear, our data 
suggest that ZBTB5 may repress transcription of the endogenous p21 gene by binding 
competition with p53, thus interfering with p53 binding onto the distal p53 binding 
elements and communication between p53 and proximal promoter bound Sp1 on the 
endogenous p21 gene. 
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Figure 4. ZBTB5 competes with p53 in binding to the distal p53 binding elements 
and increases Sp1 binding to the GC-box 5/6 in vivo. (A) Structure of the 
endogenous p21 gene. Distal p53 binding elements and proximal GC-rich elements 
are indicated. Arrows indicate binding positions of the qChIP oligonucleotide primers. 
Tsp (+1), transcription start site. (B, C) qChIP assay of binding competition between 
p53 and FLAG-ZBTB5 on the distal p53 binding regions of endogenous p21 in 
HEK293A cells. ZBTB5 competed with p53 in binding to the elements. The cells 
were transfected with increasing amounts (0-6 μg) of FLAG-ZBTB5 expression 
vector. (D) qChIP assay of FLAG-ZBTB5 and Sp1 binding on the proximal promoter 
region of endogenous p21 in HEK293A cells. ZBTB5 increases Sp1 binding to the 
elements. The cells were transfected with increasing amounts of FLAG-ZBTB5 
expression vector (0-6 μg). Antibodies against FLAG tag , p53, Sp1, and IgG were 
used in ChIP assays.   
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5.  ZBTB5 interacts with p53 or Sp1, and the interaction may be important in 
the transcriptional regulation of p53 or Sp1 target genes. 
Because transcription repression or activation can be achieved by protein-protein 
interaction between transcription factors, we investigated whether ZBTB5 interacts 
with either p53 or Sp1. Co-immunoprecipitation and Western blot assays of 
HEK293A cells transfected with FLAG-ZBTB5 expression vector revealed that 
ZBTB5 and p53 or Sp1 interact with each other in vivo (Fig. 5, B and E). The GST 
fusion protein pulldown assay also showed that the GST-ZFZBTB5 domain and 
GST-POZZBTB5 interacted with p53 or Sp1 in vitro, suggesting that ZBTB5 interact 
directly with p53 or Sp1 (Fig. 5, C and F).  
To address the functional significance of such protein-protein interactions, we 
examined whether ZBTB5 affected transcription activation by either p53 or Sp1 on 
artificial test promoter constructs designed to analyze transcription activation by the 
two factors. In the case of p53, as shown in the above, transcriptional activation of 
p21 by p53 was repressed by ZBTB5 (Fig. 3 A and B). Furthermore, transcription of 
the p53- responsive gene, pGL2-6x(p53RE)-Luc, which contains the p53 binding 
elements of p21, was repressed by ZBTB5 in Saos-2 cells (Fig. 3C). We observed 
similar results with pG13-Luc with 13 putative p53 binding sites (Fig. 5A). The data 
potentially indicate that the protein interactions may contribute to inhibiting 
transcriptional activation by p53, probably by decreasing p53 binding on the distal 
p53 binding elements (Fig. 4, B and C).  
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In contrast to p53 ZBTB5 synergistically activated transcription on the test 
promoter pG5-5x(GCbox)-Luc, indicating that the Sp1-ZBTB5 interaction might be 
an important in synergistic transcription activation (Fig. 5D). This discovery is in line 
with transcription activation of the short proximal promoter of p21 (-131 bp) by 
ZBTB5 (Fig. 2B) and increased Sp1 binding by ZBTB5 (Fig. 4D) on the proximal 
promoter of endogenous p21 gene, which is loaded with six Sp1 binding GC boxes. 
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Figure 5. ZBTB5 interacts directly with p53 and inhibits transcription activation 
of pG13-Luc by p53. (A) Transcriptional activation of pG13-Luc by ectopic p53 can 
be repressed by ZBTB5 in Saos-2 cells. pG13 contains 13 copies of the p53-binding 
element. (B) Co-immunoprecipitation of ZBTB5 and p53. HEK293A cell lysates 
were immunoprecipitated using anti-ZBTB5 antibody and analyzed by Western 
blotting using anti-p53 antibody. The lysates were also immunoprecipitated by 
anti-p53 antibody and analyzed by Western blotting using anti-ZBTB5 antibody. (C) 
In vitro GST-fusion protein pull-down assays. Left, SDS-PAGE gel of recombinant 
GST, GST-ZFZBTB5, and GST-POZZBTB5 proteins. Right, Recombinant GST, 
GST-POZZBTB5, or GST-ZFZBTB5 was incubated with [35S]-methionine-labeled 
p53, pulled down, and resolved by 10% SDS-PAGE. The gel was then exposed to 
x-ray film. Input, 10% of the p53 added in the binding reactions. (D) Transcriptional 
activation of  pG5-5x(GC-box)-Luc by Sp1 can be synergistically activated by 
ZBTB5 in HEK293A. pG5-5x(GC-box)-Luc contains 5 copies of the putative Sp1 
binding sites. (E) Co-immunoprecipitation of ZBTB5 and Sp1. HEK293A cell lysates 
were immunoprecipitated using anti-ZBTB5 antibody and analyzed by Western 
blotting using anti-Sp1 antibody. The lysates were also immunoprecipitated by 
anti-Sp1 antibody and analyzed by Western blotting using anti-ZBTB5 antibody. (F) 
In vitro GST-fusion protein pull-down assays. Recombinant GST, GST-POZZBTB5, 
and GST-ZFZBTB5 was incubated with [35S]-methionine-labeled Sp1, pulled down, 
and resolved by 10% SDS-PAGE. The gels were then exposed to x-ray film. Input, 
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10% of the labeled Sp1 added in the binding reactions. 
 
6. The POZ domain of ZBTB5 interacts with the corepressor-HDAC complex to 
deacetylate histones Ac-H3 and Ac-H4 at the proximal promoter of endogenous 
p21. 
ZBTB5 repressed transcription by direct binding competition with p53 at the 
distal p53 binding elements (Figs. 1B, 2B, 3, A and B, and Fig. 4, B and C). 
Transcriptional repressors, including some POZ-domain proteins like PLZF and 
BCL-6, often repress transcription through interaction with corepressors such as 
SMRT, NCoR, BCoR, and mSin3A. Mammalian two-hybrid assays in HEK293A cells 
using pG5-Luc, pGal4-POZZBTB5, and pVP16-corepressor fusion protein expression 
vectors demonstrated that the POZ domain interacted with SMRT, BCoR, and NCoR 
(Fig. 6A). Co-immunoprecipitation and Western blot analysis of HEK293A cell 
extracts or HEK293A cell extracts transfected with FLAG-ZBTB5 expression vector 
using anti-SMRT co-repressor and anti-HDAC3 antibodies revealed that ZBTB5 
interacted with BCoR, NCoR, SMRT, and HDAC3 in vivo (Fig. 6B), indicating that 
ZBTB5 may inhibit transcription on the p21 proximal promoter by interacting with 
the corepressor- HDAC complex via its POZ domain. In addition, GST fusion protein 
pulldown assays using the recombinant GST-POZZBTB5 protein and in vitro 
translated [S35] methionine labeled co-repressor polypeptides showed that the POZ 
domain of ZBTB5 can interact directly with SMRT, BCoR, and NCoR (Fig. 6C).     
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Corepressor complexes recruited by transcriptional repressors often contain 
HDAC proteins, and ZBTB5 fits this pattern. These HDACs deacetylate the histones 
of nearby nucleosomes to repress transcription. Treatment of HEK293A cells with the 
HDAC inhibitor trichostatin A after co-transfection with pG5-Luc, and pGal4 
-POZZBTB5 significantly affected transcriptional repression by the POZ domain and 
resulted in a significant increase in transcription (Fig. 6D). These data implicate the 
involvement of HDACs in transcriptional repression by ZBTB5.   
Corepressor-HDACs recruited by ZBTB5 may deacetylate the histones of nearby 
nucleosomes around the proximal promoter. Accordingly, we used ChIP to examine 
whether the acetylation status of histones H3 and H4 at the proximal promoter of the 
endogenous p21 gene was altered by ZBTB5-corepressor-HDACs complexes in 
HEK293A cells transfected with FLAG-ZBTB5 expression vector. The complex 
significantly decreased acetylated histones H3 and H4 at the proximal promoter of 
p21 by 40–65% (Fig. 6E). 
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Figure 6. The POZ domain of ZBTB5 interacts directly with corepressors SMRT, 
NCoR, and BCoR. And ZBTB5-corepressor-HDAC complexes deacetylate 
histones Ac-H3 and Ac-H4. (A) Mammalian two-hybrid assays of protein-protein 
interactions between the POZ-domain and corepressor proteins. HEK293A cells were 
transfected with pG5-Luc, pGal4-POZZBTB5, and pVP16-corepressor expression 
plasmids and luciferase activity was measured. (B) Co-immunoprecipitation of 
ZBTB5, BCoR, NCoR, SMRT, and HDAC3. Cell lysates prepared from HEK293A 
cells or HEK293A transfected with FLAG-ZBTB5 expression vector were 
immunoprecipitated using anti-FLAG or ZBTB5 antibody and analyzed by Western 
blotting using anti-Myc-BCoR, NCoR, SMRT and HDAC3 antibodies. (C) In vitro 
GST-fusion protein pull-down assays. Recombinant GST or GST-POZZBTB5 was 
incubated with [35S]-methionine-labeled corepressors, pulled down, and resolved by 
10% SDS-PAGE. The gels were then exposed to x-ray film. Input, 10% of the 
corepressors added in the binding reactions. (D) TSA treatment derepressed 
transcriptional repression of pG5-Luc by the Gal4-POZ ZBTB5 domain. Plasmid 
mixtures of pG5-Luc and the pGal4-POZZBTB5 expression plasmid were transiently 
co-transfected into HEK293A cells. TSA treatment derepressed transcription of the 
reporter gene, implicating the involvement of HDACs in transcriptional repression by 
ZBTB5. (E) qChIP assays of histone modification at the proximal promoter of the 
endogenous p21 gene using antibodies against Ac-H3 and Ac-H4. Cells were 
transfected with FLAG-ZBTB5 and immunoprecipitated with the indicated antibodies, 
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IgG, Ac-H3, or Ac-H4. ZBTB5 deacetylated histones Ac-H3 and Ac-H4 at the 
proximal promoter.  
 
7. ZBTB5 stimulates cell proliferation and increases the number of cells in 
S-phase  
ZBTB5 potently repressed transcription of p21, which is a major regulator of cell 
cycle arrest. HEK293A cells transfected with ZBTB5 expression vector were 
analyzed for cell cycle progression by FACS. ZBTB5 stimulated cell cycle 
progression and increased the number of HEK293A cells in S phase (21.3% in control 
versus 31.2% in HEK293A-ZBTB5) (Fig. 7A). Knockdown of endogenous ZBTB5 
mRNA by siZBTB5 RNA resulted in a decrease in the number of cells in S-phase 
(31.0% in control versus 24.6% in HEK293AZBTB5) and a concomitant increase in 
the number of cells in the G0-G1 phases (Fig. 7B). MTT assays showed the 
overexpression of ZBTB5 significantly increased cell proliferation, and knockdown 
of ZBTB5 mRNA by siRNA decreased cell proliferation in HEK293A cells (Fig. 7, C 
and D). Overall, our data suggest that ZBTB5 potently stimulates cell growth and 
proliferation and may be one of the major regulators of cell proliferation by regulating 
p21 gene expression. 
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Figure 7. ZBTB5 stimulates cell proliferation and increases the number of cells 
in S-phase. (A) FACS analysis of cell cycle progression. HEK293A cells were 
transfected with ZBTB5 expression vector or control vector, cultured, and stained 
with propidium iodide. Cell proliferation was measured by FACS. Alternatively, the 
cells were transfected with siRNA against ZBTB5 mRNA and cell cycle progression 
was analyzed. N.C., scrambled siRNA negative control. (B) MTT assay of HEK293A 
cells grown for 1, 2, 3, and 4 days. The cells were transfected with either control 
pcDNA3 vector or pcDNA3-FLAG-ZBTB5 expression vector and analyzed for cell 
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growth. Alternatively, the cells were treated with either negative control siRNA or 
siZBTB5 RNA. All assays were performed in triplicate. Error bars are included, but 
are too tight to see. 
 
 
 
 
 
 
 
 
 
 
 
 
 41
 
Figure 8. Hypothetical model of transcriptional regulation of cell cycle arrest 
gene p21 by ZBTB5. (A) p53 pathway and ZBTB5 targets. ZBTB5 represses 
transcription of the HDM2 and p21 genes. Solid line with arrowhead (→), 
transcriptional activation; solid line with ┴, transcriptional repression. Solid line with 
double arrowhead (<->), molecular interaction. (B) Hypothetical model of 
transcriptional repression of p21 by ZBTB5 under three different cellular conditions. 
ZBTB5 represses transcription of cell cycle arrest gene p21 by binding to the two 
distal p53 binding elements by competition with p53. ZBTB5 also binds to the 
proximal Sp1 binding GC-box 5/6, with an unclear function in the transcriptional 
repression of the endogenous p21 gene by ZBTB5. ZBTB5 recruits 
co-repressor–HDAC complexes, which deacetylate histones Ac-H3 and Ac-H4 at the 
proximal promoter to repress transcription. Tsp (+1), transcription start site. ZF, 
zinc-finger DNA binding domain. x, transcription repression. 
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Supplement Figure 1. ZBTB5 is a POZ-domain Krüppel-like zinc finger (POK) 
protein. Nucleotide and amino acid sequences of the ZBTB5 protein (GenBank 
Accession NP_055687.1). ZBTB5 is composed of 677 amino acids and contains a 
N-terminus POZ domain (a.a. 1-123, solid underline) and two zinc fingers, one 
typical C2H2 and one atypical C2HC types in the C-terminus (a.a. 613-677, dotted 
underline region with circles). 
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Supplement Figure 2. (A) Structures of the promoter-luciferase gene constructs of 
the p53 pathway tested in Figure 1A. Promoters of ARF, HDM2, p53, and p21 were 
fused with the luciferase gene of the pGL2-basic vector. Binding sites for 
transcriptional factors are indicated. +1, Tsp, transcriptional start site. HDM2(P2), 
p53-dependent promoter 2 of HDM2. (B) RT-PCR analysis of total RNA isolated 
from HEK293A and HCT116 cells transfected either with control adenovirus (dl324) 
or recombinant adenovirus (dl324-ZBTB5) overexpressing ZBTB5. (C) RT-PCR 
analysis of total RNA isolated from HEK293A cells transfected with either negative 
control scrambled siRNA or siZBTB5 RNA. 
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Supplement Figure 3. (A) A diagram showing the homology of amino acid 
sequences of mammalian ZBTB5 proteins. All mammalian ZBTB5s show a sequence 
homology greater than 92%. (B) Tissue distribution of mouse Zbtb5 mRNA 
expression. RT-PCR analysis of cDNA prepared from total RNA of male FVB mouse 
tissues. (C) Immunocytochemistry of human FLAG-ZBTB5 in HEK293A cells 
transfected with FLAG-ZBTB5 expression vector. ZBTB5 was detected in the 
nucleus. 
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IV. DISCUSSION 
 
We found that ZBTB5 repressed transcription of the p21 and HDM2 genes. Our 
investigation on transcription regulation of the cell cycle arrest gene p21 by ZBTB5 
revealed that p21 is the direct target of ZBTB5. ZBTB5 regulates transcription of the 
p21 gene through a molecular mechanism that involves p53, and the two upstream 
p53-responsive elements. ZBTB5 bound to distal p53 binding elements by competing 
with p53, and repressed the contribution of p53 to transcription. The site has been 
shown to mediate the induction of p21 gene expression by genotoxic stresses. 
Accordingly, DNA damaging signals that result in p53 medicated induction of p21 
gene can be blocked by ZBTB5. Overall, these molecular features of ZBTB5 may 
explain how ZBTB5 acts as a regulatory protein of cell growth and proliferation and, 
potentially in oncogenesis, by inhibiting p21 transcription. 
ZBTB5 binds to the proximal Sp1 binding GC box 5/6, which is a direct target of 
regulation by Sp1 and Sp-family members. Intriguingly, ZBTB5 binding to this 
particular site increased transcription activation of short promoter by Sp1, although in 
the much longer promoter context, ZBTB5 repressed transcription of p21. In line with 
this finding, ChIP assays showed that ZBTB5 significantly increases Sp1 binding to 
the proximal promoter region, which may explain transcription activation on the short 
proximal promoter.  
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Protein interaction between proximal promoter-bound Sp1 and distal p53 is 
important in the transcriptional activation of the p21 gene, even in the basal level of 
p53. It appears that the presence of p53 and p53 binding element affects the role of 
ZBTB5 either as a transcription repressor or activator of the p21 gene. Although 
ZBTB5 represses transcription of p21 in the p53-/- HEK293A and HCT116 p53-/- 
cells, ZBTB5 stimulates transcription significantly, even on the longer p21 promoter 
construct or endogenous p21 gene in HCT116 p53-/- cells, probably by the molecular 
interaction between ZBTB5 and Sp1 on the proximal promoter.3 ZBTB5 may disrupt 
protein- protein interaction by Sp1 and p53 on the p21 gene to repress transcription. 
This observation raised the possibility that ZBTB5 is a unique POK family 
transcription regulator that can act either as a positive or negative regulator of p21 
transcription depending on the cellular p53 status, i.e. mutation, absence, or presence. 
Based on our data, we propose a hypothetical model of transcriptional regulation of 
p21 by ZBTB5 in p53-positive cells  (Fig. 8). Under normal cellular conditions 
where p53 expression is low and ZBTB5 expression is absent or lower than Sp1, the 
p21 gene is expressed in low basal levels driven by Sp1, and cells proliferate normally. 
Challenge with a genotoxic stress induces production of tumor suppressor p53, which 
binds to the distal p53 responsive elements and activates transcription of p21 by 
interacting with the Sp1 bound at the proximal GC boxes. The induced p21 arrests 
cell cycle progression, allowing cells to repair DNA damage. In cells without DNA 
damage where ZBTB5 expression is high, ZBTB5 represses transcription directly by 
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binding to both the distal p53 binding elements and proximal GC-box 5/6. ZBTB5 
bound to the regulatory elements recruits the corepressor-HDAC complex, causing 
deacetylation of histone Ac-H3 and Ac-H4 around the proximal promoter and 
repressing transcription. 
Whencells are under genotoxic stress and ZBTB5 expression is high or in 
cancerous tissues that have high levels of both p53 and ZBTB5, ZBTB5 represses 
transcription directly by binding to both the distal p53 binding elements and proximal 
GC-box 5/6. Although p53 expression is also highly induced under these conditions, 
p53 has to compete with ZBTB5 to bind to the distal p53 binding elements and is also 
affected by molecular interactions between p53 and ZBTB5 that further impede 
binding. Although p53 is present, transcription of p21 is potently repressed by ZBTB5. 
Cells proliferate without cell cycle arrest, mutations accumulate, and cells are likely 
to undergo oncogenic transformation (Fig. 8). These series of molecular events may 
be important in the oncogenesis of retinoblastoma and muscle cancer, where 
expression of ZBTB5 is high. 
Although it can bind to the distal p53 binding elements to repress transcription of 
p21, ZBTB5 also has characteristics of Sp1 family Kru¨ppel-like zinc finger proteins 
and binds to some of the GC boxes that are similar to the GC boxes recognized by 
Sp1. Our findings suggest that some GC boxes recognized by Sp1 may be 
transcriptional activation targets of ZBTB5 and that Sp1-ZBTB5 binding competition 
or enhancement may be a general mechanism of transcriptional regulation of some 
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ZBTB5 target genes. 
Molecular interactions occurring both in the proximal and distal promoter of the 
p21 gene are unique and may also be applicable to the transcription regulation of 
other genes such as HDM2. Indeed, the HDM2 gene has one binding site for p53 in 
the P2 promoter region and is transcriptionally activated by p53. In contrast, p21 has 
two p53 binding elements. The difference in the binding site number may explain 
why ZBTB5 repressed transcription of p21 more potently. 
In our laboratory we have observed that other POZ-domain transcription factors 
such as FBI-1 (Pokemon), ZBTB2, and PLZF repress transcription of p21 by acting 
on the distal p53 binding elements and proximal Sp1 binding GC-box.4 The common 
theme of transcriptional regulation of cell cycle regulator gene p21 by POZ-domain 
class transcription factors is that distal p53 binding elements are the primary target 
sites of transcription repression, which is eventually conveyed into the histone 
deacetylation of the proximal promoter. 
Although the molecular events involving ZBTB5 on the p53 binding elements are 
relatively straightforward, their action in the short proximal promoter seems more 
complex, probably because Sp1 family members, MIZ-1, c-Myc, BCL-6, FBI-1, and 
ZBTB5 are integrated into the region to either activate or repress transcription. 
ZBTB5 activates transcription by acting on the short proximal promoter. ZBTB5 may 
act as transcription activator in the region by interacting with transcription regulators 
such as Sp family members and MIZ-1 that can bind to the juxtaposed regulatory 
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elements. The physiological importance of the transcription activation of the short 
p21 promoter (-131 bp) by ZBTB5 is unclear at present because ZBTB5 apparently 
represses endogenous p21 gene transcription. Taken together, our findings indicate 
that ZBTB5 may play a critical role in regulating important biological processes such 
as DNA repair and cell growth, differentiation, and apoptosis by regulating the 
transcription of p21 and HDM2 of the p53 pathway. 
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ABSTRACT (in Korean) 
 
새로운 POK 계 발암 유발 후보 단백질 ZBTB5의 세포주기 억제 p21 
유전자의 발현조절 기전 규명 
<지도교수 허 만 욱>  
 
연세대학교 대학원 의과학과 
 
고 동 인 
   
인간 게놈 프로젝트를 통해 알려지게 된 많은 유전자들은 최근 기능 
동정을 중심으로 많은 연구가 진행되고 있다. 이 계열의 단백질은 
단백질-단백질간의 상호작용 모티프로 작용하는 BTB/POZ domain을 
가지며 다양한 세포기능 조절에 관여한다.  
    세포 기능조절 단백질은 수십-수백 개의 아미노산으로 구성된 조각 
(모듈: module)로 구성되어 있으며, 모듈을 중심으로 일어나는 
단백질-단백질 상호작용에 의하여 고유의 기능을 발휘한다. 주로 
POZ-도메인을 갖는 단백질들은 세포 죽음, 염색체 구조조절, 암 발생, 
유전자 발현조절 등에 관련되어 있다. 이에 우리 팀은 BTB/POZ 도메인중 
하나인 ZBTB5를 분리, 동정하였으며, RT-PCR을 통해 생쥐에서 심장과 
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 갈색지방을 제외한 거의 모든 조직에서 ZBTB5가 발현되고 있음을 
확인하게 되었다. SAGE 분석 결과 안암과 근육암에서 ZBTB5의 발현량이 
현저하게 증가되어 있음을 알 수 있다. 최근 BTB/POZ 도메인 단백질 중 
하나인 FBI-1이 세포주기를 촉진시킨다는 보고로 proto-oncogene으로서 
주목을 받고 있는데, 우리는 아마도 ZBTB5 역시 세포주기에 관계되는 
Arf-Mdm2-p53-p21의 promoter에 영향을 끼칠 것으로 예상하고 
luciferase assay를 실시하였다. 흥미롭게도 p53 경로의 하위단계 
조절인자인 p21의 전사만 억제하는 것을 관찰하였다. 이는 상위단계의 
조절여부와는 상관없이 하위단계 인자를 조절하게 때문에 세포주기 조절에 
기여하는 바가 크다고 판단하여 p21의 전사를 억제 하는 ZBTB5의 
작용기전을 연구하였다.     
ZBTB5 는 직접적으로 세포주기 조절인자인  p21 유전자 프로모터의 
근접조절 부위의 GC Box 5/6 번 자리와 Distal 부위의 p53 결함부위에 
징크핑거를 통하여 결합하여 p21 의 발현을 감소시킴을 GST pull- down , 
EMSA, ChIP을 통하여 밝히었다. 또한, 기존의 알려진 p53과 Sp1 과의 
관계는 ChIP(Chromatin Immunoprecipitation Assay)를 통해 p53과는 
결합자리를 두고 경쟁하며, Sp1의 결합은 증가시킴을 알 수 있었다. 이와 
같은 방법으로 ZBTB5는 POZ와 징크핑거 도메인을 통하여 corepressor 
히스톤 디아세틸 복합체 중 BCoR, NCoR 그리고 SMRT와 상호작용을 
하는 것으로 나타났고 최종적으로 p21 프로모터 근접조절 부분의 
히스톤을 디아세틸화 시킴으로써 전사를 억제시킨다. 이러한 전사 
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억제효과가 세포기능 조절에 어떠한 영향을 미치는가를 관찰하기 위하여 
MTT 와 FACS 분석을 실시하였다. 그 결과 ZBTB5가 세포성장과 
세포주기의 조절에 중요하며 특히, 세포주기중 S 기의 세포수가 현저히 
증가함을 관찰하였다. 
 결과적으로, ZBTB5는 세포주기를 멈추게 하는 p21 의 발현을  
감소시킴으로써 세포의 증식을 촉진할 수 있는  원암 유전자의 성격을 
가지고 있음을 발견하였다 
 
 핵심되는 말 : BTB/POZ, 암,  p53,  p21,  ZBTB5,  세포주기, 전사인자, 
원암 유전자 
 
